ShockWave and Guardant reported fantastic things, while Abiomed and Inogen dropped precipitously on some scary updates.
The semiconductor software specialist raises its full-year guidance again after another strong quarter.
This newly public company is growing at breakneck speed and has a massive opportunity ahead of it.
Shares continue to rebound after an SEC filing reveals that an insider has been quietly adding to his position.
The cloud-based software maker snags a buyout offer.
Shares jump after the newly public medical-device company reports upbeat earnings.
Shares of the beaten-down telecom rise after an activist investor discloses a big position.
Shares start to rebound after a gut-wrenching decline.
A bull and a bear walk into a room and (civilly!) talk about the most controversial stock on the market.
These three companies are pumping fresh air into the lungs of millions all over the world.
Traders are fleeing after the company reports mixed second-quarter results and slashes full-year guidance.
Shares jump after the company reports upbeat first-quarter results and boosts guidance.
Management boosts full-year guidance after a strong second quarter.
Revenue and profit fell hard after Skyworks temporarily stopped doing all business with one of its largest customers.
The company's numbers in its latest report weren't great in absolute terms, but the pipeline continues to grow and management believes that it's on pace to return to profitability by the end of the year.
Shares pop after the company reports better-than-expected second-quarter results and offers optimistic guidance.
Shares soar after the company announces that it has accepted a buyout offer.
The identity governance software company reported upbeat second-quarter results and raised its full-year guidance.
Product launches are putting stress on the organization and have caused a few of the company's key metrics to slip.
Shares sink after the medical-device maker reported weak second-quarter results and slashed guidance. Again.